Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

Abstract Introduction We developed and validated a clinically applicable decision tree for the use of cerebrospinal fluid biomarkers in the diagnosis of Alzheimer's disease (AD). Methods Subjects with probable AD (n = 1004) and controls (n = 442) were included. A decision tree was modeled using...

Full description

Bibliographic Details
Main Authors: Rosha Babapour Mofrad, Niki S.M. Schoonenboom, Betty M. Tijms, Philip Scheltens, Pieter Jelle Visser, Wiesje M. van derFlier, Charlotte E. Teunissen
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
CSF
Tau
Online Access:https://doi.org/10.1016/j.dadm.2018.10.004